TransMedics GroupTMDX

那斯達克 · USD
125.04
+1.89
(+1.53%)
收盤 12/17 04:59 (UTC+8)
盤後 
125.04 
125.04 
(0.00%)
12/17 04:59 (UTC+8)

財務數據

損益表

loading
載入中...
icon
  • 0.52
  • 0.66
  • 0.81
  • 0.97
  • 1.14
  • 1.09
  • 1.22
  • 1.44
  • 1.57
  • 1.44
icon
  • 26.26
  • 26.62
  • 22.19
  • 19.31
  • 18.02
  • -4.85
  • 11.83
  • 18.02
  • 9.64
  • -8.61
  • icon
    營業收入(億)
  • icon
    季增長率(%)
單位:美元千元
年季
2025/Q3
2025/Q2
2025/Q1
2024/Q4
2024/Q3
2024/Q2
2024/Q1
2023/Q4
2023/Q3
2023/Q2
營業收入淨額
143,823
157,370
143,537
121,624
108,761
114,305
96,850
81,174
66,430
52,465
營業成本
59,24860,78155,30949,61147,91645,04436,88833,25025,76815,724
營業毛利
84,575
96,589
88,228
72,013
60,845
69,261
59,962
47,924
40,662
36,741
營業費用
61,27560,02260,78563,36956,92256,753-45,32168,99737,647
研發費用
15,26015,93417,16016,46414,26613,85811,38010,76111,1328,291
推銷及管理費用
46,01544,08843,62546,90542,65642,89536,16134,56030,65329,356
非經常性項目費用
--------27,212-
其他營業費用
----------
營業利益
23,300
36,567
27,443
8,644
3,923
12,508
12,421
2,603
-28,335
-906
其他收入及費用
3,2223,0912,6941,9163,9393,2683,5704,8654,9962,431
利息費用
3,4913,4763,4613,5713,6173,6233,5983,6053,5902,505
稅前純益
23,031
36,182
26,676
6,989
4,245
12,153
12,393
3,863
-26,929
-980
所得稅
-1,2881,27599413229-41196-168-1,50721
稅後純益
24,319
34,907
25,682
6,857
4,216
12,194
12,197
4,031
-25,422
-1,001
基本每股稅後盈餘(元)
0.711.030.760.200.130.370.370.12-0.78-0.03
稀釋每股稅後盈餘(元)
0.660.920.700.200.110.350.350.12-0.78-0.03
基本平均股數(千股)
34112.0033912.0033721.0033592.0033441.0033119.0032760.0032644.0032614.0032545.00
稀釋平均股數(千股)
40748.0040558.0039914.0035211.0035683.0035288.0034678.0034179.0032614.0032545.00
還原基本每股稅後盈餘(元)
0.711.030.760.200.130.370.370.12-0.78-0.03
還原稀釋每股稅後盈餘(元)
0.660.920.700.200.110.350.350.12-0.78-0.03
還原基本平均股數(千股)
34,11233,91233,72133,59233,44133,11932,76032,64432,61432,545
還原稀釋平均股數(千股)
40,74840,55839,91435,21135,68335,28834,67834,17932,61432,545
EBITDA(千元)
33,37146,38936,27416,24013,03920,37520,29311,073-21,4462,917

大家都在看

HOT